Sildenafil For Suspension
Product Images NDC 31722-136

18 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 31722-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Struct (Sildenafil Structure)

Struct (Sildenafil Structure)
Chemical structure diagram depicting the molecular structure of Sildenafil and a related compound, likely representing the active ingredient Sildenafil in powdered form for suspension. The diagram shows atoms and chemical bonds clearly, corresponding to the product Sildenafil Powder for suspension by Camber Pharmaceuticals.*
FDA Label Image

Fig-1 (Sildenafilfig 1)

Fig-1 (Sildenafilfig 1)
A horizontal bar chart showing the fold change with 90% confidence intervals for area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil when coadministered with various interacting drugs. Recommendations for dose adjustment or coadministration are listed alongside, with drugs including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir.*
FDA Label Image

Fig-2 (Sildenafilfig 2)

Fig-2 (Sildenafilfig 2)
A chart depicting the fold change and 90% confidence intervals for pharmacokinetic parameters (AUC, Cmax, INR, BT) of Sildenafil when coadministered with various interacting drugs. The graph compares changes relative to the interacting drug alone, with recommendations on dose adjustments ranging from no dose adjustment to coadministration not recommended for some drugs.*
FDA Label Image

Fig-3 (Sildenafilfig 3)

Fig-3 (Sildenafilfig 3)
A line chart showing change from baseline (mean) over Weeks 4, 6, and 12 of a study. The chart compares the effects of Sildenafil 40 mg TID, Placebo, Sildenafil 80 mg TID, and Sildenafil Drug TID. The vertical axis measures change from baseline, while the horizontal axis shows the weeks of study.*
FDA Label Image

Fig-4 (Sildenafilfig 4)

Fig-4 (Sildenafilfig 4)
A forest plot showing placebo-corrected changes in 6-minute walk distance (meters) comparing Sildenafil 20 mg TID to placebo across various subgroups, including baseline walk distance, etiology of pulmonary arterial hypertension (PAH), pulmonary hypertension criteria, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance index.*
FDA Label Image

Fig-5 (Sildenafilfig 5)

Fig-5 (Sildenafilfig 5)
A line graph comparing the percentage of participants without clinically worsening events over 112 days between two groups: placebo and Sildenafil. The y-axis represents the percentage without worsening events, and the x-axis shows the days from randomization. Sildenafil group maintains a higher percentage without events compared to placebo throughout the study period.*
FDA Label Image
FDA Label Image

Logo-1 (Sildenafil Camberlogo 1)

FDA Label Image

Figure-a (Sildenafilfig A)

Figure-a (Sildenafilfig A)
Illustration showing components of Sildenafil oral suspension packaging and dosing equipment, including a bottle with cap and adaptor labeled Sildenafil 10 mg/mL for oral suspension, and an oral dosing syringe with labeled tip, barrel, and plunger.*
FDA Label Image

Fig-b (Sildenafilfig B)

Fig-b (Sildenafilfig B)
An instructional illustration showing a hand holding a bottle with arrows indicating shaking up and down and rotating motions. Next to the bottle is a stopwatch indicating timing, demonstrating how to properly shake and mix the contents before use.*
FDA Label Image

Fig-c (Sildenafilfig C)

Fig-c (Sildenafilfig C)
An instructional illustration labeled Figure C shows a hand gripping and pressing down on a child-resistant cap atop a medication bottle, with an arrow indicating a downward push and another arrow showing a clockwise turning motion on the cap, demonstrating how to open the bottle.*
FDA Label Image

Fig-d (Sildenafilfig D)

Fig-d (Sildenafilfig D)
An instructional line drawing showing hands using a syringe or dropper to withdraw liquid from a bottle. One hand is pressing on the syringe plunger, while the other hand holds the liquid-filled bottle, illustrating the process of drawing up medication for suspension.*
FDA Label Image

Fig-e (Sildenafilfig E)

Fig-e (Sildenafilfig E)
An instructional illustration showing a hand holding a bottle upside down while a syringe is inserted into the bottle to draw liquid out, labeled as Figure E.*
FDA Label Image

Fig-f (Sildenafilfig F)

Fig-f (Sildenafilfig F)
An instructional illustration showing hands extracting liquid from a bottle with a syringe, likely demonstrating dosage measurement for Sildenafil Powder for Suspension 10 mg/mL by Camber Pharmaceuticals. The diagram includes an upward arrow indicating the syringe drawing liquid from the bottle.*
FDA Label Image

Sildenafilfig-g (Sildenafilfig G)

Sildenafilfig-g (Sildenafilfig G)
An instructional illustration labeled Figure G demonstrating the oral administration of medication to an adult using a syringe directed into the mouth. The image shows a hand holding the syringe toward the lips, indicating the method of dosing.*
FDA Label Image

Fig-h (Sildenafilfig H)

Fig-h (Sildenafilfig H)
Illustration showing a hand holding the cap of a bottle labeled Sildenafil Powder for Suspension 10 mg/mL. The arrows indicate twisting the cap to open or close the bottle, demonstrating proper handling for oral suspension preparation.*
FDA Label Image

Fig-i (Sildenafilfig I)

Fig-i (Sildenafilfig I)
Instructional illustration showing a water faucet dispensing water into two oral syringes as part of a preparation or administration process, likely related to Sildenafil Powder for Suspension. The diagram is labeled as Figure 1.*
FDA Label Image

Carton-label (Sildenafil Carton)

Carton-label (Sildenafil Carton)
Sildenafil 10 mg/mL for Oral Suspension label from Camber Pharmaceuticals, Inc. The label states the product is for oral use only, grape flavored, and must be shaken well before each use. It includes reconstitution directions for a 112 mL suspension following mixing with water. The label also displays the NDC 31722-136-31 and notes the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.